Detalles de la búsqueda
1.
Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia.
J Antimicrob Chemother
; 75(6): 1546-1553, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32211756
2.
Ceftolozane-Tazobactam Population Pharmacokinetics and Dose Selection for Further Clinical Evaluation in Pediatric Patients with Complicated Urinary Tract or Complicated Intra-abdominal Infections.
Antimicrob Agents Chemother
; 63(6)2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30962340
3.
Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30745392
4.
Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir.
J Antimicrob Chemother
; 74(3): 710-717, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30541077
5.
Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection.
J Gastroenterol Hepatol
; 34(9): 1597-1603, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30779220
6.
Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment.
Eur J Clin Pharmacol
; 75(5): 665-675, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30680407
7.
Effect of Hepatic Impairment on the Pharmacokinetics of Grazoprevir, a Hepatitis C Virus Protease Inhibitor.
Antimicrob Agents Chemother
; 61(12)2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28947470
8.
No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.
Eur J Clin Pharmacol
; 73(5): 593-600, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28233047
9.
The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis C virus genotype 1 infection without cirrhosis.
Gastroenterology
; 147(2): 366-76.e6, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24727022
10.
Virologic resistance analysis from a phase 2 study of MK-5172 combined with pegylated interferon/ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection.
Clin Infect Dis
; 59(12): 1657-65, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25266289
11.
Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.
Br J Clin Pharmacol
; 78(3): 587-98, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24617605
12.
Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients.
Pediatr Infect Dis J
; 43(3): 203-208, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241643
13.
Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: a randomized phase II study.
Hepatology
; 56(3): 884-93, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22473713
14.
Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIV.
AIDS
; 37(7): 1057-1064, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36927740
15.
Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults.
Biomed Pharmacother
; 169: 115851, 2023 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37976891
16.
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.
Hepatol Commun
; 7(3): e0031, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36790337
17.
A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy Japanese adults.
Clin Transl Sci
; 15(7): 1753-1763, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35506164
18.
Immune-viral dynamics modeling for SARS-CoV-2 drug development.
Clin Transl Sci
; 14(6): 2348-2359, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34121337
19.
Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults.
Clin Drug Investig
; 41(2): 133-147, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33527237
20.
Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal Clearance.
Int J Antimicrob Agents
; 57(4): 106299, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33567333